Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

20.75
-0.7200-3.35%
Post-market: 20.800.0485+0.23%17:27 EDT
Volume:1.22M
Turnover:25.37M
Market Cap:3.54B
PE:9.02
High:21.42
Open:21.25
Low:20.75
Close:21.47
52wk High:28.35
52wk Low:13.40
Shares:170.49M
Float Shares:115.85M
Volume Ratio:0.57
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.30
EPS(LYR):2.30
ROE:39.89%
ROA:4.76%
PB:2.88
PE(LYR):9.02

Loading ...

Mizuho Upgrades ACADIA Pharmaceuticals to Outperform From Neutral, Adjusts Price Target to $35 From $29

MT Newswires Live
·
Feb 23

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), ACADIA Pharmaceuticals (ACAD) and Progyny (PGNY)

TIPRANKS
·
Feb 23

U.S. RESEARCH ROUNDUP-Akamai Technologies, Albemarle, Nordson

Reuters
·
Feb 23

Earning Preview: ACADIA Pharmaceuticals this quarter’s revenue is expected to increase by 5.36%, and institutional views are predominantly bullish

Earnings Agent
·
Feb 18

ACADIA’s ACP-211 Trial Targets Difficult-to-Treat Depression: What Investors Should Watch

TIPRANKS
·
Feb 12

ACADIA Pharmaceuticals Is Maintained at Perform by Oppenheimer

Dow Jones
·
Feb 07

BUZZ-Australia's Neuren sinks as Rett drug setback prompts Jefferies PT, outlook cuts

Reuters
·
Feb 06

ACADIA Pharmaceuticals Inc. kündigt Veröffentlichung von Finanzzahlen an

Reuters
·
Feb 05

Analysts Are Neutral on Top Healthcare Stocks: Replimune Group (REPL), ACADIA Pharmaceuticals (ACAD)

TIPRANKS
·
Feb 04

ACADIA Pharmaceuticals Price Target Maintained With a $37.00/Share by HC Wainwright & Co.

Dow Jones
·
Feb 03

ACADIA Pharmaceuticals Inc. : Deutsche Bank Cuts Target Price to $32 From $33

THOMSON REUTERS
·
Feb 03

U.S. RESEARCH ROUNDUP-Adobe, Exxon Mobil, Stellar Bancorp

Reuters
·
Feb 03

BUZZ-Australia's Neuren sinks on setback for Rett treatment drug application from European regulator

Reuters
·
Feb 03

Acadia Expects Negative Opinion from EU Regulators for Rett Syndrome Treatment

Dow Jones
·
Feb 03

BRIEF-Acadia Pharmaceuticals Provides Update On Regulatory Submission For Trofinetide For The Treatment Of Rett Syndrome In The European Union

Reuters
·
Feb 03

ACADIA Pharmaceuticals Inc - to Request Re-Examination of Chmp Opinion

THOMSON REUTERS
·
Feb 03

ACADIA Pharmaceuticals Provides Update on Regulatory Submission for Trofinetide for the Treatment of Rett Syndrome in the European Union

THOMSON REUTERS
·
Feb 03

ACADIA Pharmaceuticals Inc - Receives Negative Trend Vote on Trofinetide Maa

THOMSON REUTERS
·
Feb 03

U.S. RESEARCH ROUNDUP-Air Products, Chevron, UnitedHealth

Reuters
·
Feb 02

Acadia Pharmaceuticals a solid opportunity here, says Canaccord

TIPRANKS
·
Jan 30